Crinetics Pharmaceuticals
Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers.
HQ location
San Diego, United States
Website
Launch date
Employees
Market cap
$2.8b
Enterprise value
$1.6b
Share price
$28.76 CRNX
Recent deals
Authorizing premium user...